Proteus Digital Health

Proteus Digital Health™ is pioneering a new category of products, services and data systems based on integrating medicines with ingestible, wearable, mobile and cloud computing. Its core technology - the digital health feedback system - provides an unprecedented view into an individual's personal health choices and physiologic response, allowing patients to better manage their health and more effectively collaborate with caregivers and clinicians, while enabling new information-based business models. Proteus has received a CE mark in Europe and FDA market clearance in the U.S. for its wearable and Ingestible Sensor™ devices. Headquartered in Redwood City, Calif., Proteus is privately held and funded by Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka®, Oracle®, ON Semiconductor® and other investors. Further information is available at: www.proteus.com